The FDA has warned that ketamine and compounded ketamine products aren’t approved to deal with any psychiatric disorder. This means that they haven’t been demonstrated for being Protected or effective. In 2019, the FDA approved a nasal spray called esketamine (Spravato) that’s derived from ketamine for treatment-resistant depression, but only https://sandrah555dsh3.anchor-blog.com/profile